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Abstract 
Background: Meningeosis neoplastica is a diffuse metastatic spread of tumor cells in the subarachnoid space. 
Although first recognized in 1870, systematic investigations regarding cerebrospinal fluid (CSF) constituents in this 
condition are scarce.
Methods: Routine CSF samples analyzed from 2001 to 2012 at the Laboratory of Clinical Neurochemistry, University 
of Göttingen, were re-evaluated. Patients, whose CSF contained malignant cells were included in this study.
Results: Patients (n = 132, age 59.1 ± 29.1, 58% women) were identified, whose CSF contained malignant cells. The 
most frequent primary tumor was breast cancer (32.6%), followed by lung cancer (25.0%) and hematologic malignan-
cies (21.2%). The most frequent clinical symptoms were affections of cranial nerves (41.7%), psychiatric abmormalities 
(32.6%) and radicular lesions of the lower extremities (20.5%). CSF cell counts ranged from 0 to 4692 cells/μl (median 
4 cells/μl) and were elevated in 50%. The CSF-to-serum albumin ratio was abnormal in 69.4%. It ranged from 1.8 to 
330 x 10-3 (median 17.5 x 10-3). Total CSF protein ranged from 166 to 15,840 mg/l (median 1012 mg/l). CSF lactate was 
elevated (>2.4 mmol/l) in 65.2% [3.6 mmol/l (1.3/15.6 mmol/l); median (minimum/maximum)]. In 50% of all patients 
CSF lactate was ≥3.5 mmol/l. The CSF cell counts correlated significantly with the CSF lactate levels and the CSF 
protein contents. In 56 of 118 CSF samples (47.5%) ferritin was elevated, and in 25 of 65 carcinoma patients (38.5%) 
an intrathecal production of carcinoembryonic antigen (CEA) was detected. Granulocytes were found in 52.7% of the 
CSF samples. The percentages of granulocytes and lymphocytes were higher in samples with an elevated cell count.
Conclusion: In approximately 50% of CSF samples with meningeosis neoplastica the CSF cell count is not elevated. 
Diagnosis may be missed when only CSF samples with elevated cell counts are subjected to cytological analysis. CSF 
lactate and protein and the CSF-to-serum albumin ratio are frequently increased in meningeosis neoplastica. The 
differential diagnosis between meningeosis neoplastica and central nervous infections, in particular tuberculous or 
fungal meningitis, can be difficult.
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Background
Meningeosis neoplastica, the infiltration of the menin-
ges and the subarachnoid space by malignant cells as a 
consequence of metastatic cancer, was first described 
by Karl Joseph Eberth as early as 1870 [1]. Meningeo-
sis neoplastica is the generic term for all infiltrations of 
the meninges by malignancies including (1) Meningeosis 
carcinomatosa as the metastatic spread of a carcinoma 
to the meninges,  (2) Meningeosis lymphomatosa with 
leptomeningeal involvement by hematologic malignan-
cies and (3) dissemination to the meninges of primary 
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tumors of the central nervous system, e.g. germinomas, 
medulloblastomas, primitive neuroectodermal tumors, 
ependymomas and malignant gliomas. Meningeosis car-
cinomatosa occurs in 3–8% of all cancer patients. Among 
solid tumors, the most frequent tumor types associated 
with meningeosis carcinomatosa are carcinomas of the 
lung and breast, and melanoma. Meningeosis lymphoma-
tosa can be observed in approximately 5–15% of patients 
with hematologic malignancies. Meningeal involvement 
is most common with high-risk lymphomas and acute 
lymphocytic leukemia [2, 3]. Tumor cells migrate into the 
meninges either hematogeneously via small meningeal 
arteries and veins or by direct infiltration from the vicinity, 
i.e., from metastases or primary tumors in the skull, spi-
nal cord or brain [4, 5]. After entry into the subarachnoid 
space or ventricles, malignant cells spread with the cer-
ebrospinal fluid (CSF) along the whole CSF space. These 
cells frequently accumulate in regions with a reduced cir-
culation velocity of the CSF, i.e., in the basal cisterns, the 
cauda equina or the hippocampal fissure [2].
Frequent clinical symptoms suggesting meningeo-
sis neoplastica are headache, changes in mental status, 
difficulty in walking, nausea, vomiting, diplopia, lower 
motor weakness, limb paresthesia, back or neck pain, 
and radiculopathy [6]. Many antineoplastic drugs do not 
readily cross the blood–CSF and blood–brain barrier, but 
the doses of antineoplastic drugs necessary to produce 
effective CSF concentrations after direct injection into 
the CSF space are comparatively low (e.g., 10–15 mg for 
methotrexate, 40  mg for cytosine–arabinoside) [7]. For 
this reason, high antineoplastic drug concentrations in the 
CSF with low systemic toxicity can be reached by intrath-
ecal chemotherapy. The magnetic resonance tomographic 
and CSF findings in meningeosis neoplastica can be con-
founded with infectious diseases of the CNS, particularly 
CNS tuberculosis and fungal meningoencephalitis.
An early diagnosis of meningeosis neoplastica, before per-
sisting neurologic deficits have developed, permits earlier 
and potentially more effective treatment, thereby leading to 
a better quality of life in affected patients [6]. Since the indi-
cation for intrathecal chemotherapy relies on the detection 
of malignant cells in the CSF, all efforts must be undertaken 
to firmly establish the diagnosis. The present study aims at 
characterizing the CSF findings in a large group of patients 
with meningeosis neoplastica. Special emphasis was placed 
on the possible contribution of routine parameters for the 
differential diagnosis between meningeosis neoplastica and 
infectious or autoimmune diseases of the CNS.
Methods
Patients
The medical files including lumbar or ventricular CSF of 
patients with meningeosis neoplastica, who were treated 
between January 1, 2001, and December 31, 2012, with 
different clinical symptoms in the University Hospital 
Göttingen, in the Protestant Hospital Göttingen-Weende 
and other regional hospitals, were retrospectively ana-
lyzed. The inclusion criterion was the presence of tumor 
cells as assessed by morphological criteria. Clinical 
symptoms were assessed by review of the patients’ medi-
cal files. We also assessed the results, when cranial com-
puter tomography (CCT) or magnetic resonance imaging 
(CMRI) was performed. The study was approved by the 
Ethics Committee of the Medical Faculty of the Georg-
August University Göttingen, Germany.
CSF analysis
After lysis of the erythrocytes, CSF cells were counted 
manually in a Fuchs-Rosenthal chamber. A cell count 
of  ≤4/μl was considered normal. CSF cell differentia-
tion was performed after cell sedimentation by means 
of a cytocentrifuge (Omnifuge 2.0 ORS, Thermo Scien-
tific, Darmstadt, Germany) and May-Grünwald-Giemsa 
(MGG) staining (Merck, Darmstadt, Germany). Cytology 
was performed on MGG-stained cytospins. The appear-
ance of tumor cells depended on the origin of the primary 
tumor. Tumor cells were in general larger than mononu-
clear hematopoietic cells. Furthermore, they frequently 
showed a marked increase in the nuclear/cytoplasmic 
ratio, basophilic cytoplasm, hyperchromasia, irregular 
nuclear membrane, pseudopodia and increased number 
of nucleoli. Especially in the case of epithelial cancer, 
tumor cells frequently lay in clusters and occasionally, in 
part atypical, mitotic figures were observed. Depending 
on the primary tumor, tumor cells occasionally showed 
evidence for mucus production or pigmentation. The 
CSF protein content was measured by nephelometry 
after precipitation with trichloroacetic acid in a Dosascat 
nephelometer (Dosatec, Gilching, Germany) using Gesa-
mteiweiß UC Standard FS (DiaSys Diagnostic Systems, 
Holzheim, Germany) [8]. CSF and serum albumin, and 
immunoglobulins IgG, IgA and IgM were determined by 
nephelometry (BN ProSpec, Siemens Healthcare Diag-
nostics, Tarrytown, NY, USA), and the respective albu-
min and immunoglobulin CSF/serum quotients (IgG, 
IgA, IgM) were calculated and plotted in Reiber-Felgen-
hauer nomograms [9]. CSF oligoclonal IgG bands were 
detected by isoelectric focusing in polyacrylamide gels; 
for the comparison of CSF and serum bands samples 
were blotted at equalized IgG concentrations and, after 
immobilization on a nitrocellulose membrane, stained 
with anti-human IgG antibodies [9–11]. CSF lactate was 
determined enzymatically using the lactate oxidase reac-
tion cleaving lactate into pyruvate and hydrogen perox-
ide. The resulting chinonimine concentration, which 
was proportional to the CSF lactate concentration, was 
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quantified in an ELISA reader at 620  nm. CSF lactate 
concentrations  ≤2.4  mmol/l were considered normal; 
CSF lactate concentrations  ≥3.5  mmol/l are generally 
considered an indicator of CNS bacterial infection.
In addition to cytology, protein biomarkers were estab-
lished especially for carcinomas invading the CNS and 
the leptomeninges [12]. Carcinoembryonic antigen 
(CEA), an oncofetal antigen and tumor marker particu-
larly for gastrointestinal, breast or lung adenocarcinoma, 
was found to be secreted into the CSF of patients with 
meningeosis carcinomatosa [13]. Carcinoembryonic anti-
gen (CEA) in CSF and serum was measured by enzyme 
immunoassay using antibody-coated beads and a CSF 
volume of 3 ml in order to increase the sensitivity of the 
assay [10, 14]. Since the molecular mass of CEA and IgA 
is approximately equal, intrathecal secretion of CEA was 
quantified by using the Reiber-Felgenhauer nomogram 
for the immunoglobulin IgA [14].
The CSF concentration of ferritin was measured by 
nephelometry (BN ProSpec, Siemens Healthcare Diag-
nostics, Tarrytown, NY, USA).
Statistics
Statistical calculations were performed with GraphPad 
Prism software (GraphPad Software, La Jolla, USA). Data 
was described by means  ±  standard deviations (SD), 
when normally distributed. In the absence of normal dis-
tribution data was described by medians and interquar-
tile ranges or as medians and ranges (minima/maxima). 
For univariate analyses, we used Mann–Whitney U 
test in the absence of normal distribution. The relation 
between CSF cell count and CSF lactate concentration 
and CSF protein was assessed by Spearman’s rank corre-
lation coefficient, rS. p values ≤0.05 were considered sta-
tistically significant.
Results
A group of 132 patients with meningeosis neoplas-
tica [age 16–97  years (59.1  ±  29.1  years; mean  ±  SD), 
77 women, 55 men)] was included in this study. In 128 
patients lumbar CSF and in four patients ventricular CSF 
was studied.
Clinical symptoms of the patients studied are depicted 
in Table  1. Cranial nerve palsies were most frequent, 
followed by psychiatric abnormalities (mainly fluctuat-
ing level of consciousness and confusion) and radicu-
lar symptoms of the lower extremities and headache. In 
32.6% breast carcinoma was the primary malignoma, 
followed by bronchial carcinomas (25.0%), hematologic 
malignancies (21.2%), gastrointestinal tumors (8.3%) 
and neoplasias of the skin (3.8%). All other malignancies 
including primary brain and spinal tumors accounted for 
9.1% of the cases (Fig. 1). 
97 patients with cytologically proven meningeosis neo-
plastica received cranial imaging [CCT (n =  19), CMRI 
(n  =  24) or both (n  =  54)] within a short time period 
before or after the diagnostic lumbar or ventricular CSF 
analysis. In 50 of these patients (51.5%), typical signs of 
meningeosis neoplastica were present on CCT or CMRI.
The results of CSF analysis in patients with meningeosis 
neoplastica are presented in Table 2. The CSF cell count 
(leukocytes and tumor cells cannot be distinguished reli-
ably in the Fuchs-Rosenthal cytometer, and erythrocytes 
were lysed before counting) was elevated (>4 cells/μl) 
in the CSF samples of 66 patients and normal (≤4 cells/
μl) in the other 66 patients. CSF pleocytosis ≥100 cells/
µl was present in 18 patients (13.6%) , and four patients 
had a CSF pleocytosis ≥500 cells/μl. Malignant cells were 
detected in all CSF samples (inclusion criterion). Differ-
entiation into lymphocytes, monocytes and granulocytes 
was carried out in the CSF of 55 patients (28 of them with 
normal cell count and 27 with pleocytosis).
Overall, lymphocytes were the most abundant cell 
population. Granulocytes were found in 52.7% of the CSF 
samples, in only two patients was the percentage of gran-
ulocytes >50%. Both of them had more than 500 cells/µl. 
In the CSF of patients with >4 cells/μl, lymphocytes and 
granulocytes were significantly more frequent than in the 
CSF with ≤4 cells/μl [lymphocytes 92% (72/94%) versus 
77.5% (67/87.8% ), median (25th/75th quartile) (Mann-
WhitneyU test: p < 0.01); granulocytes 19% (2/31%) ver-
sus 3.5% (0/8.3%) (Mann–Whitney U test: p  =  0.013). 
Table 1 Clinical symptoms of  the patients studied 
(n = 132) upon admission
Cranial nerve palsies were most frequent, followed by psychiatric abnormalities 
(mainly fluctuating level of consciousness and confusion)
Symptoms in the order of decreasing frequency All patients
n (%)
Cranial nerve palsy 55 (41.7%)
Psychiatric abnormalities 43 (32.6)




Radicular sensory symptoms of the lower extremities 21 (15.9)
Non-radicular sensory abnormalities 18 (13.6)
Para- or tetraparesis 17 (12.9)
Aphasia 14 (11.4)
Nuchal rigidity 12 (9.1)
Cognitive decline 11 (8.3)
Radicular motor symptoms of the upper extremities 11 (8.3)
Epileptic seizures 10 (7.6)
Radicular sensory symptoms of the upper extremities 5 (3.8)
Fever 2 (1.5)
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Conversely, monocytes were less frequent in CSF sam-
ples with pleocytosis than in those with a normal cell 
count [8% (6/14%) versus 12% (10/20%), p < 0.01].
Total CSF protein was elevated (>450  mg/l) in 102 of 
130 patients (78.5%). The CSF protein was positively cor-
related with the CSF cell count (n = 130, Spearman’s rank 
correlation coefficient rS = 0.45, p < 0.001) (Fig. 2a). The 
CSF-to-serum albumin ratio was abnormal in 84 of 121 
patients (69.4%). Intrathecal synthesis of IgG or IgA or 
IgM antibodies as assessed by the Reiber–Felgenhauer 
nomograms was detected in the CSF of 13 patients: four 
showed an isolated intrathecal synthesis of IgG, two syn-
thesis of IgA, and nine synthesis of IgM. In two patients, 







breast carcinoma bronchial carcinomas hematologic malignancies
gastrointesnal tumors neoplasia of the skin other tumors
Fig. 1 Pie chart of the frequency of various malignant diseases in the study population
Table 2 Cerebrospinal fluid analysis in patients with meningeosis neoplastica
In 50% of CSF samples with meningeosis neoplastica the CSF cell count was not elevated. The CSF-to-serum albumin ratio was abnormal in 69.4%, and total CSF 
protein was elevated (>450 mg/l) in 102 of 130 patients (78.5%). CSF lactate was elevated (>2.4 mmol/l) in 65.2%
In 32.6% breast cancer was the primary malignoma, followed by bronchial carcinomas (25.0%), hematologic malignancies (21.2%), gastrointestinal tumors (8.3%) and 






CSF cells (/µl) excluding erythrocytes 66 (50) 66 (50) 4 (0/4692)
CSF protein (mg/l) 28 (21.5) 102 (78.5) 1012 (166/15,840)
QAlbumin × 10−3 37 (30.6) 84 (69.4) 17.5 (1.8/330)
CSF lactate (mmol/l) 46 (34.8) 86 (65.2) 3.6 (1.3/15.6)
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of antibodies (one patient: IgG plus IgM; one patient: IgG 
plus IgA). Nephelometry detected intrathecal immuno-
globulin synthesis in 10 lymphoma and three carcinoma 
patients. By isoelectric focusing, intrathecal IgG synthe-
sis was detected in the CSF of 25 of 62 patients (40.3%), 
i.e., isoelectric focusing was by far more sensitive than 
nephelometry in detecting intrathecal IgG synthesis.
Cerebrospinal fluid lactate was elevated (>2.4 mmol/l) 
in 65.2% [3.6  mmol/l (1.3/15.6  mmol/l); median (mini-
mum/maximum)]. In 66 of 132 patients (50%), CSF 
lactate was strongly elevated (≥3.5  mmol/l). The CSF 
lactate concentration was correlated with the CSF cell 
count (n =  132, Spearman’s rank correlation coefficient 
rS = 0.42, p < 0.001) (Fig. 2b).
Ferritin and CEA were not measured in all samples, but 
only upon request of the clinician in charge of the patient. 
In 56 of 118 CSF samples (47.5%) ferritin was elevated, 
and in 25 of 81 cases (30.9%) an intrathecal production 
of CEA was detected. No intrathecal CEA production 
was detected in lymphoma patients. Of the 65 patients 
with meningeosis carcinomatosa, 25 patients (38.5%) had 
intrathecal CEA synthesis.
Discussion
Clinical signs and symptoms of the patients included in 
this study were very similar to those reported by oth-
ers [6]. CSF analysis is the key laboratory investigation 
to diagnose/confirm meningeosis neoplastica. If this 
diagnosis is suspected, repeated analyses of CSF may be 
necessary to prove the presence of malignant cells in the 
CSF, as this is the diagnostic cornerstone of meningeo-
sis neoplastica. Furthermore, the detection of malignant 
cells in CSF is the prerequisite for the start of intrathecal 
therapy, and one criterion for successful treatment is the 
disappearance of tumor cells. In our study the presence 
of malignant cells in CSF was the inclusion criterion, 
i.e., all CSF samples evaluated contained malignant cells. 
Surprisingly, 50% of the CSF samples included had nor-
mal cell counts. In a previous study, 32% of patients with 
cytologically-proven meningeosis neoplastica had nor-
mal CSF cell counts [15]. These studies illustrate that cli-
nicians cannot rely on a normal CSF cell count to exclude 
meningeosis neoplastica, and cytological examination of 
CSF should always be included in the routine work-up of 
CSF analysis. Careful cytopathologic analysis is necessary 
in all CSF samples, when infiltration of the CSF space by 
malignant cells is suspected.
When the CSF cell count is elevated and malignant cells 
are not present or are overlooked, differentiation between 
meningeosis neoplastica and infections or autoimmune 
diseases affecting the CSF space can be difficult. In par-
ticular, tuberculous meningitis can be confounded with 
meningeosis neoplastica, because the clinical symptoms 
and CSF abnormalities can be similar. Moreover, many 
patients suffering from malignant diseases are immu-
nosuppressed either by chemotherapy or the underlying 
disease. They, therefore, are prone to develop CNS infec-
tions with M. tuberculosis, fungi and other opportunistic 
pathogens, which also can cause CSF alterations similar 
to those observed in meningeosis neoplastica.
Elevated CSF lactate is not specific for certain diseases. 
Meningeosis neoplastica can cause a CSF lactate eleva-
tion [16], but a concentration ≥3.5 mmol/l is considered 
an indicator of bacterial or fungal meningoencephalitis 
[11]. Most of the CSF lactate originates from host cells, 
in particular, leukocytes and neurons. Even in bacte-
rial meningitis, ≥95% of the CSF lactate originates from 
anaerobic glycolysis of host cells and not from bacteria 
in the CSF [17]. In the present study, CSF lactate was 
correlated with the CSF cell count. In a recent receiver 
operating characteristic (ROC) curve analysis, CSF lac-
tate had the highest accuracy for discriminating bacterial 
from viral meningitis with a cutoff set at 3.5 mmol/l [18]. 
Using a cutoff of 3.5  mmol/l, CSF lactate was also very 
useful to discriminate between cryptococcal or tuber-
culous meningitis and HIV chronic meningitis [19]. In 







































Fig. 2 The CSF protein (n = 130) a and CSF lactate levels (n = 132) 
b correlated with the CSF cell counts (Spearman’s rank correlation 
coefficient rS = 0.45, p < 0.001 for CSF protein and rS = 0.42, p < 0.001 
for lactate)
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acute Lyme neuroborreliosis, an atypical bacterial CNS 
infection with low pathogen concentrations in CSF and 
symptoms, which may resemble meningeosis carcino-
matosa (in particular, radicular lesions and cranial nerve 
involvement), only 5 of 118 patients (4%) had a CSF lac-
tate ≥3.5 mmol/l, and the mean CSF lactate level was not 
elevated [20]. This implies that CSF lactate concentra-
tions ≥3.5 mmol/l can help in discriminating meningeo-
sis neoplastica from viral meningitis, neuroborreliosis, 
mitochondriopathy and many other conditions, but not 
from neurotuberculosis and fungal meningoencephalitis.
Meningeosis neoplastica frequently is associated with 
an inflammatory response. The presence of intrathecal 
IgG, IgA and IgM synthesis as well as the high proportion 
of lymphocytes in the CSF of patients with meningeosis 
neoplastica indicate a strong involvement of the adaptive 
immune system. As in neuroborreliosis, isoelectric focus-
ing was more sensitive for detecting an intrathecal IgG 
synthesis than the Reiber–Felgenhauer nomogram [20]. 
The presence of granulocytes in the CSF in neoplastic 
meningeosis suggests a contribution of the innate immune 
system to the inflammatory reaction. In tuberculous men-
ingitis which also is characterized by a strong elevation of 
CSF lactate and total protein and a moderate elevation of 
cell counts (10–500 cells/μl), neutrophil predominance 
(>50%) [21] was a strong predictor of tuberculous menin-
gitis with a sensitivity of 54% and a specificity of 98% [22]. 
Since only two of the 55 CSF samples in our study, where 
differential cell counts were carried out, contained  >50% 
granulocytes, neutrophilic predominance in CSF is an 
argument against the diagnosis of meningeosis neoplas-
tica. However, in nearly 50% of patients with tuberculous 
meningitis, neutrophil predominance is absent, and the 
differentiation between these two diseases relies on bac-
teriologic exams (Ziehl-Neelsen stain, culture, polymer-
ase chain reaction) and on the cytological identification of 
tumor cells.
The CSF protein concentration correlated positively 
with the CSF cell count. One explanation for this is an 
abnormal blood–CSF barrier function with increased 
permeability for leukocytes and serum-derived proteins. 
In particular, the leptomeningeal structures and the epi-
thelial cells of the choroid plexus can be infiltrated by 
neoplastic cells, resulting in an increased permeability for 
serum compounds [23]. Another explanation for this cor-
relation is a decreased CSF flow rate due to the obstruc-
tion of the sites of CSF absorption, especially arachnoid 
granulations and the perineural spaces of the cranial and 
spinal nerves by malignant cells or leukocytes. As a con-
sequence of the CSF flow reduction, the protein gradient 
between serum and CSF can decrease [24].
Ferritin CSF concentrations were elevated in 56 of 118 
patients (47.5%). CSF ferritin concentrations are elevated 
after intracranial bleeding and in neoplastic and menin-
gitic CNS diseases, but this parameter is neither specific 
nor sensitive. An elevated CSF ferritin reliably, but non-
specifically indicates severe CNS disease [25].
Carcinoembryonic antigen was measured in 81 
patients. In patients with metastatic CEA-producing 
tumors, diffusion of CEA across the blood–CSF and 
blood–brain barrier cannot be neglected. The CSF 
concentrations depend on the respective serum con-
centration, and absolute cut-off values are not appro-
priate. Because of the similar molecular mass of CEA 
and IgA, the Reiber–Felgenhauer nomogram for IgA 
can be used to detect intrathecal CEA synthesis [10, 14, 
26]. In 25 patients of 65 carcinomas cases (38.5%) the 
Reiber–Felgenhauer nomogram indicated intrathecal 
CEA synthesis. Using the IgA nomogram, the detection 
of intrathecal CEA is considered a very specific, but not 
very sensitive indicator of meningeosis carcinomatosa 
or cerebral metastases. A normal or undetectable CSF-
to-serum ratio of CEA does not exclude infiltration of 
CNS compartments by  carcinoma  cells, lymphomas 
and primary brain tumors do not produce CEA [14]. 
Another method to detect intracranial synthesis of CEA 
compares the CSF-to-serum ratio of CEA with the CSF-
to-serum albumin ratio and assumes intrathecal syn-
thesis when the CSF-to-serum ratio of CEA is greater 
than the CSF-to-serum albumin ratio determined on 
the same day. Since the molecular mass of CEA is larger 
than albumin, this method is less sensitive than the use 
of the IgA nomogram [10]. We doubt that CEA CSF 
concentrations without knowledge of the corresponding 
serum levels are of value for the detection of meningeo-
sis carcinomatosa. Others, however, have reported that 
the combination of CSF concentrations of CEA, neuron 
specific enolase (NSE) and cytokeratin 19 fragments 
(CYFRA21-1) using cut-off values without considera-
tion of the respective serum levels appears to be useful 
for the detection of meningeal carcinomatosis of lung 
cancer [27].
Conclusions
The two main findings of this study are: (1) In half of the 
CSF samples with meningeosis neoplastica the CSF cell 
count is not elevated. Therfore, diagnosis can be missed 
when only CSF samples with elevated cell counts are 
subjected to cytological analysis. (2) CSF lactate and pro-
tein and the CSF-to-serum albumin ratio are frequently 
increased in meningeosis neoplastica. The differential 
diagnosis between meningeosis neoplastica and central 
nervous infections, in particular tuberculous or fungal 
meningitis, can be difficult. For the detection or exclu-
sion of malignant cells in the CSF, cytology performed by 
an experienced pathologist is necessary.
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